Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

LIPASE - ANVISA Registration 80146502401

Access comprehensive regulatory information for LIPASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502401 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80146502401
Registration Details
ANVISA Registration Number: 80146502401
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família ARCHITECT Lipase2
Risk Class II

Registration Details

80146502401

25351050797202501

56998701000116

Company Information

Ireland
PT: IRLANDA

Dates and Status

May 05, 2025

VIGENTE

09/18/2025 19:00:01